Diagnosis and treatment of incomplete Kawasaki disease in children
JIAO Fu-Yong, MU Zhi-Long, DU Zhong-Dong, YANG Xiao-Dong, SHEN Jie, XIANG Wei, WANG Hong
Shaanxi Provincial Kawasaki Disease Treatment Center/Children's Hospital of Shaanxi Provincial People's Hospital, Xi'an 710068, China
Abstract Kawasaki disease (KD) is a febrile disease mainly observed in children aged <5 years, with medium- and small-vessel vasculitis as the main lesion. Although KD has been reported for more than 50 years and great progress has been made in the etiology and pathology of KD in recent years, there is still a lack of specific indicators for the early diagnosis of KD, especially with more difficulties in the diagnosis of incomplete Kawasaki disease (IKD). At present, there are no clear diagnostic criteria for IKD, which leads to the failure of the timely identification and standardized treatment of IKD in clinical practice and even induce the development of coronary artery lesion. This article reviews the concept, epidemiological features, diagnosis, treatment, and follow-up management of IKD, in order to deepen the understanding of IKD among clinical workers and help to improve the clinical diagnosis and treatment of KD in China.
Key words :
Incomplete Kawasaki disease
Diagnosis
Treatment
Child
Received: 27 September 2022
[1]
LI Shi-Yu, DING Yan. Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance [J]. CJCP, 2023, 25(3): 244-249.
[2]
XIAO Li-Ping, ZHOU Li-Na, CHEN Jun-Jie, ZHANG Yan, TANG Xue-Mei, ZHOU Juan. A preliminary study on the role of V-domain Ig suppressor of T cell activation in juvenile idiopathic arthritis [J]. CJCP, 2023, 25(3): 272-277.
[3]
SONG Li-Fang, WANG Li, TANG Zhi-Hui, XIAN Yi-Xin, LIU Kai, MA Yuan-Ning. Clinical features of autoimmune encephalitis secondary to epidemic encephalitis B in 5 children [J]. CJCP, 2023, 25(3): 302-307.
[4]
SUN Wen-Juan, SUN Yong-Hong. Recent research on the nuclear factor-kappa B signaling pathway in cardiac injury in children with Kawasaki disease [J]. CJCP, 2023, 25(3): 250-252.
[5]
ZHENG Ya-Xin, JIANG Li. Recent research on cytokines associated with anti-N-methyl-D-aspartate receptor encephalitis [J]. CJCP, 2023, 25(3): 321-327.
[6]
LIU Zhi, ZHU Lei, SHENG Li-Ping, HUANG Qing-Chen, QIAN Tong, QI Bo-Xiang. A pilot study on the effects of early use of valproate sodium on neuroinflammation after traumatic brain injury [J]. CJCP, 2023, 25(3): 253-258.
[7]
HUANG Jin-Yue, ZHANG Bi-Li, LIU Wei. Clinical diagnostic techniques for rare genetic diseases in children: current status, advances, and thoughts [J]. CJCP, 2023, 25(3): 308-314.
[8]
SU Hang, DUAN Feng-Yang, REN Xian-Qing, ZHANG Xia, YAN Yong-Bin. Clinical features of children with coronavirus disease 2019 caused by Delta variant infection in different age groups [J]. CJCP, 2023, 25(3): 289-294.
[9]
ZHONG Lin, ZHANG Jing, ZUO Peng-Xiang. The mediating role of emotion regulation strategies between symptoms and anxiety problems in children with attention deficit hyperactivity disorder [J]. CJCP, 2023, 25(3): 259-264.
[10]
QIN Li-Jiao, MAI Hui-Rong. Recent research on cognitive impairment in children with acute lymphoblastic leukemia [J]. CJCP, 2023, 25(3): 315-320.
[11]
YANG Wen-Yu, LIU Li-Peng, LIU Fang, QI Ben-Quan, CHANG Li-Xian, ZHANG Li, CHEN Xiao-Juan, ZOU Yao, CHEN Yu-Mei, GUO Ye, ZHU Xiao-Fan. Clinical features and prognosis of juvenile myelomonocytic leukemia: an analysis of 63 cases [J]. CJCP, 2023, 25(3): 265-271.
[12]
WANG Jun-Yan, ZHU Xiao-Ping, ZHANG Yu, LUO Chong, TANG Xue-Mei, ZHOU Juan. Role of CD4+ NKG2D+ T cells in the disease activity of juvenile idiopathic arthritis [J]. CJCP, 2023, 25(2): 166-171.
[13]
YUAN Wen-Jun, CHENG Jin, LIU Chun-Mei, LIU Jun-Han, SHI Meng-Yue, LU Shu-Wen, GUAN Feng-Jun. Distribution of memory B cell subsets in peripheral blood of children with frequently relapsing nephrotic syndrome [J]. CJCP, 2023, 25(2): 172-178.